Financials
Financial year 2024
CLAESSENS ENDOCRINOLOGIE from Léglise, company number BE0648777966, closed financial year 2024 with a result of € 79,951 after tax. For that financial year CLAESSENS ENDOCRINOLOGIE recorded a gross margin of € 147,403 and equity of € 529,563. Compared with financial year 2023, the result moved from € 87,177 to € 79,951. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2025.
€ 529,563
▲ 18% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 79,951
▼ 8% vs 2023
Profit after tax over the fiscal year.
€ 469,166
▲ 8% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 510,963.
People and assets in 2024
€ 63,029
▲ € 62,384 vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 116,597
▼ 7% vs 2023
€ 9,456 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 4,452
▲ € 4,104 vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 29,834
▲ 31% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 122,106 | € 125,065 | € 141,468 | € 147,403 | ▲ 4% |
| Profit after taxes | € 75,378 | € 82,102 | € 87,177 | € 79,951 | ▼ 8% |
| Equity | € 280,333 | € 362,435 | € 449,612 | € 529,563 | ▲ 18% |
| Total debts | € 316,756 | € 319,662 | € 330,021 | € 332,165 | ▲ 1% |
| Cash | € 254,351 | € 339,309 | € 433,138 | € 469,166 | ▲ 8% |
| Land & buildings | € 279,153 | € 283,334 | € 277,661 | € 272,094 | ▼ 2% |
| Retained profit | € 261,733 | € 343,835 | € 431,012 | € 510,963 | ▲ 19% |
| Bank debt | € 144,072 | € 135,060 | € 125,903 | € 116,597 | ▼ 7% |
| Balance sheet total | € 601,323 | € 686,097 | € 783,632 | € 865,963 | ▲ 11% |
Key figures of CLAESSENS ENDOCRINOLOGIE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to CLAESSENS ENDOCRINOLOGIE?
What happened at CLAESSENS ENDOCRINOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 79,951 (▼ 8% vs 2023). filed late Source: NBB ↗
- New establishment in Arlon. KBO
- Start of the company according to the CBE. KBO
In short
From € 75,378 profit in 2021 to € 79,951 profit in 2024.
Paid € 110,849 in corporate taxes since 2021.
Best year ever: 2023, with € 87,177 profit.
A new publication or filing at CLAESSENS ENDOCRINOLOGIE? We notify you, reason included.
Follow CLAESSENS ENDOCRINOLOGIEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind CLAESSENS ENDOCRINOLOGIE is Anick CLAESSENS.
Directors
According to the 2024 annual accounts
Anick CLAESSENS
Director
Establishments
Establishment units
Physical locations of this company
Rue des Combattants, Les Fossés 4
6860 Léglise
Rue des Déportés 137
6700 Arlon
Active since 18 February 2016
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0648.777.966
- VAT number
- BE 0648.777.966
- Registered office
- Rue des Combattants, Les Fossés 4, 6860 Léglise
- Names & denominations
- CLAESSENS ENDOCRINOLOGIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 February 2016
- Peppol
- Active · Active since 10 Sept 2025
- Activities · NACE
Activiteiten van medisch specialisten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten